Response to "Do different treatment strategies of galcanezumab have similar effect on migraine?"

: We are grateful for our colleagues' interest (1) in our recent paper (2). We apologise if we were not clear. We concluded, as quoted, that galcanezumab may (our emphasis) offer an effective treatment option for patients with episodic migraine who have failed prior preventives.